STSS - Sharps Technology Inc.
1.79
-0.060 -3.352%
Share volume: 126,294
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$1.85
-0.06
-0.03%
Fundamental analysis
33%
Profitability
35%
Dept financing
36%
Liquidity
31%
Performance
30%
Performance
5 Days
0.56%
1 Month
2.29%
3 Months
-30.62%
6 Months
-82.52%
1 Year
503.30%
2 Year
402.24%
Key data
Stock price
$1.79
DAY RANGE
$1.77 - $1.86
52 WEEK RANGE
$0.01 - $18.23
52 WEEK CHANGE
$306.82
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
Company detail
CEO: Robert M. Hayes
Region: US
Website: sharpstechnology.com
Employees: 3
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Region: US
Website: sharpstechnology.com
Employees: 3
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Sharps Technology Inc. researches, designs, develops, manufactures, distributes, and sells safety syringe products. Sharps Provensa is an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Recent news